About
A European pharmaceutical company built around North American cannabis expertise.
Motagon s.r.o. sources, releases and distributes medical cannabis for European patients.
Motagon exists because there is a gap between where good cannabis medicine is grown and where the patients who need it are treated. Closing that gap takes licences, a quality system, and relationships in the pharmacy channel. We built all three.
Motagon was founded by corporate partners with backgrounds in pharmaceutical quality, healthcare business development and North American cannabis expertise.
Our mission
To make the optimal cannabis-based medicine available to every patient who can benefit from it, released to a standard a pharmacist can verify and a prescriber can trust.
Licences held
- EU-GMP Part I
Finished medicinal products · since July 2026 - EU-GMP Part II
Active substances · since 2022 - EU-GDP
Good Distribution Practice - Narcotics handling
Czech Ministry of Health
Every licence is publicly verifiable on the European Medicines Agency’s EudraGMDP database.